# CROWN BIOSCIENCE, INC: Form D filings

CROWN BIOSCIENCE, INC, a biotechnology company in Santa Clara, CA, filed 3 Form D notices with the SEC between 2011 and 2013. The latest, on September 13, 2013, reports $30.5 million sold of a $32.2 million offering to 14 investors.

Find out what CROWN BIOSCIENCE, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CROWN%20BIOSCIENCE%2C%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CROWN%20BIOSCIENCE%2C%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcrown-bioscience-inc-1381815)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CROWN%20BIOSCIENCE%2C%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CROWN%20BIOSCIENCE%2C%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcrown-bioscience-inc-1381815)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3375 Scott Boulevard, Suite 108, Santa Clara, CA, 95054
- Phone: (603) 583-4408
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: California
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1381815

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 13, 2013 | Amendment | $32,154,281 | $30,466,178 | $1,688,103 | 14 | Apr 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1381815/000138181513000003/0001381815-13-000003-index.htm) |
| May 19, 2011 | Amendment | $28,800,000 | $28,800,000 | $0 | 14 | Apr 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1381815/000138181511000007/0001381815-11-000007-index.htm) |
| May 2, 2011 | New notice | $28,800,000 | $27,800,000 | $1,000,000 | 14 | Apr 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1381815/000138181511000006/0001381815-11-000006-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Andrew Alexander Lo | Director |  |
| C.K. Alexander Cheng | Director |  |
| Lee Alexander Ting | Director |  |
| Jean-Pierre Alexander Wery | Executive Officer |  |
| Hongbo Alexander Lu | Director |  |
| Guoliang Alexander Yu | Executive Officer |  |
| Nisa Alexander Lin | Director |  |
| Sandy Alexander Chau | Director |  |
| Yue Alexander Wu | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of Sep 9, 2013](https://specstream.ai/data/form-d/week/2013-09-09) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CROWN BIOSCIENCE, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).